Latest news
Low Dose CAR T Therapy Achieved High Remission Rates - EMJEMJ · Sun, 09 Aug 2026 15:03:11 GMTSafety and Efficacy of IL-10–Expressing CAR T-Cell Therapy in Relapsed or Refractory DLBCL - The ASCO PostThe ASCO Post · Mon, 03 Aug 2026 14:55:35 GMTStudy Shows Potential for Low-Dose CAR T, With Implications for Increased Access - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Fri, 31 Jul 2026 07:00:00 GMT